• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Fewer People Are Strategizing With Prescription Drug Choices to Control Their Health Care Costs

By
Erik Sherman
Erik Sherman
Down Arrow Button Icon
By
Erik Sherman
Erik Sherman
Down Arrow Button Icon
March 19, 2019, 8:23 AM ET

The U.S. Has the highest drug prices in the world. Despite enormous expenses in research and marketing, pharmaceutical companies have the tenth highest profit levels among all industries.

Despite some attention from Congress and the administration, prices remain high and promise to continue do so, at least in the immediate future. You might expect that people look for ways, whether good or bad, to lower their drug expenses. But the number doing so has fallen since 2013, according to a new report from the Centers for Disease Control and Prevention.

About 60% of adults from 18 to 64 years have been prescribed medication over the last 12 months. Seventy percent of prescription drug medications carry out-of-pocket costs. To reduce those expenses, adults can ask a doctor for lower-cost-medication, fail to take medicine as proscribed, or use an alternative therapy. The use of all three strategies has dropped since 2013.

The percentage of adults asking their doctors for less expensive choices dropped from 25.8% in 2013 to 19.8% in 2015. Now the percentage is 19.5%.

In 2013, 14.9% of adults with prescriptions did not take the medicine as directed—like rationing doses. By 2017, the percentage of adults doing so was 11.4%. Use of alternative therapies as a cost-cutting measure dropped from 5.8% in 2013 to 4.8% in 2015 and back to 5.4% by 2017.

But drug control strategies have unequal health impacts. Taking too little medicine can reduce the effectiveness of the treatment and endanger a patient, as happened to a diabetic young man in 2017. Working off his mother’s health insurance, he tried to use less insulin, ultimately resulting in his death less than a month later.

About the Author
By Erik Sherman
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.